Abstract
Voltage-dependent calcium channels constitute the main entry pathway for calcium into excitable cells. They are heteromultimers formed by an α1 pore-forming subunit (CaVα1) and accessory subunits. To achieve a precise coordination of calcium signals, the expression and activity of these channels is tightly controlled. The accessory β-subunit (CaVβ), a membrane associated guanylate kinase containing one guanylate kinase (β-GK) and one Src homology 3 (β-SH3) domain, has antagonistic effects on calcium currents by regulating different aspects of channel function. Although β-GK binds to a conserved site within the α1-pore-forming subunit and facilitates channel opening, β-SH3 binds to dynamin and promotes endocytosis. Here, we investigated the molecular switch underlying the functional duality of this modular protein. We show that β-SH3 homodimerizes through a single disulfide bond. Substitution of the only cysteine residue abolishes dimerization and impairs internalization of l-type CaV1.2 channels expressed in Xenopus oocytes while preserving dynamin binding. Covalent linkage of the β-SH3 dimerization-deficient mutant yields a concatamer that binds to dynamin and restores endocytosis. Moreover, using FRET analysis, we show in living cells that CaVβ form oligomers and that this interaction is reduced by CaVα1. Association of CaVβ with a polypeptide encoding the binding motif in CaVα1 inhibited endocytosis. Together, these findings reveal that β-SH3 dimerization is crucial for endocytosis and suggest that channel activation and internalization are two mutually exclusive functions of CaVβ. We propose that a change in the oligomeric state of CaVβ is the functional switch between channel activator and channel internalizer.
Keywords: Calcium Channels, Endocytosis, Membrane Proteins, Plasma Membrane, Protein Motifs, Dynamin, MAGUK, Src Homology 3, Beta-subunit
Introduction
Voltage-dependent calcium channels link membrane depolarization to transient increases in cytosolic calcium concentration, which in turn mediate a variety of cellular processes, including gene expression, contraction, neurotransmission, and exocytosis (1). To direct the signal to a specific subset of an extensive family of effectors, cells are endowed with a complex network of regulators that constrain the timing and spreading of the calcium increase. The subset of voltage-dependent calcium channels that are activated by strong depolarization, also called high voltage-activated (HVA)3 channels, are heteromultimers consisting of a central pore-forming subunit (CaVα1) that associates with one or more accessory subunits. Among them the accessory β-subunit (CaVβ) has traditionally been recognized as one of the most important modulator of HVA channels (1–3). More recently, it has been shown that the same subunit mediates several other cellular processes (for review, see Ref. 4), including regulation of insulin secretion (5), gene transcription (6) and endocytosis (7). Four CaVβ isoforms (CaVβ1 to CaVβ4) have been cloned from different nonallelic genes. Crystallographic studies of three of these provided the molecular basis for its functional versatility by identifying two protein-protein interactions modules: an Src homology 3 (β-SH3) and a guanylate kinase (β-GK), which are typically found in members of the membrane-associated guanylate kinase family of scaffolding proteins (see Fig. 1A) (8–10). The functional multiplicity of CaVβ is achieved by establishing pairwise interactions with other protein partners beside CaVα1. How CaVβ sorts out the different molecular targets inside the cell remains elusive. One of these partners is dynamin, the GTPase that scisses newly formed vesicles from the plasma membrane during endocytosis (11, 12). Dynamin contains a proline-rich region with several PxxP consensus motifs that serve as docking sites for SH3 domains (13). SH3/proline-rich region-mediated interactions appear to recruit dynamin to areas of endocytosis (14, 15). SH3 domains are small modules found in a variety of proteins that mediate inter- and intramolecular interactions (16). Several conserved amino acids are critical for binding to the PxxP motif in the ligand proteins. These residues are also present in the SH3 domain of CaVβ, but they appear occluded in the crystal structure (8–10). However, the β-SH3 domain does bind to dynamin (7), suggesting that the PxxP binding motif becomes exposed by a yet to be discovered regulatory event. Furthermore, following association of the SH3 domain of CaVβ with dynamin, the number of channels at the plasma membrane is reduced (7). Conversely, association of the GK domain of CaVβ with a highly conserved binding motif in CaVα1, known as the α1-interaction domain (AID) (17) favors the coupling between voltage and channel opening in HVA channels (see Fig. 1A) (18). Although much has been speculated over the mechanism by which CaVβ alters the open probability of the channel (19–21), how this protein is rerouted to the endocytic pathway has not yet been explored.
Several canonical SH3-containing proteins form dimers to accomplish a particular function (22–24). Amphysisin, the major binding partner of dynamin in mammalian brain, forms heterodimers between two similar isoforms to recruit dynamin to clathrin-coated pits in nerve terminals (22). The islet-brain 1 scaffold protein and CT10 regulator of kinase-like adaptor protein are examples in which homodimerization appears to be involved in regulation of function (23, 24). Here, we investigated the oligomeric state of β-SH3 and show that dimerization of β-SH3 engages CaVβ toward the endocytic pathway.
EXPERIMENTAL PROCEDURES
cDNA Constructs and Recombinant Proteins
The CaV1.2 channel construct and dynamin has been described elsewhere (7). Full-length CaVβ2a (Swiss-Prot entry Q8VGC3), β-SH3, and β-SH3 C113A monomer and concatamer versions were prepared as described (7, 25). All recombinant protein constructs bear a His6 tag fused at the N-terminal end of the protein. GST alone and GST fused to the intracellular loop encompassing the AID site from CaV2.3, hereby referred as to GST-AID, were produced as described previously (25).
Pulldown Assays
Pulldown assays with His-tagged β-SH3 derivatives were performed as described (7). Cobalt-based agarose beads were coupled to the proteins and incubated with pre-cleared extract from tsA201 cells transfected with a dynamin-encoding plasmid 24 to 36 h earlier. Bound proteins were eluted with SDS-PAGE loading buffer and resolved on SDS-PAGE. Immunoblot analysis was done using anti-dynamin antibody (BD Biosciences).
Xenopus Oocyte Preparation, Injection, and Electrophysiological Recordings
Xenopus laevis oocytes were prepared, injected, and maintained as in a previous report (26). Electrophysiological recordings on CaV1.2-expressing oocytes were performed using the cut-open oocyte technique with a CA-1B amplifier (Dagan Corp., Minneapolis MN) as described (25). Gating currents were separated from ionic currents by stepping the membrane voltage near the reversal potential for the permeant ion (Ba2+) (7). Data acquisition and analysis were performed using the pCLAMP system and software (Axon Instruments Inc., Foster City, CA). Currents were filtered at 2 kHz and digitized at 10 kHz. Linear components were eliminated by P/-4 prepulse protocol that consisted of four consecutives pulses a fourth of the amplitude of the test pulse. Current traces during these prepulses were added together and substracted from the current traces obtained with the main pulse.
FRET Analysis
CaVβ2 was fused at its carboxyl-terminal end to either YFP (CaVβ-YFP) or CFP (CaVβ-CFP) by standard PCR methods. Mammalian tsA201 cells grown on coverslips (15-mm diameter) were co-transfected with YFP- and CFP-tagged CaVβ2-encoding plasmids using LipofectamineTM (Invitrogen). Spectral analysis of living tsA210 cells co-expressing CFP- and YFP-tagged CaVβ2 constructs were performed according to Kobe et al. (27). Quantitative linear unmixing FRET (lux-FRET) analysis in cuvettes and at the single cell level were performed 18–24 h after transfection as described recently (28, 29). Lux-FRET allows determination of FRET efficiencies of donor-acceptor pairs in the presence of free donor and acceptor molecules.
Blue Native (BN)-PAGE
BN-PAGE was done as described (30). Briefly, proteins were incubated for 30 min at room temperature with loading buffer alone or supplemented with either 10 mm DTT, 1% SDS, or both. Proteins were resolved in a gradient polyacrylamide gel (4–25%) overnight at 4 °C using cathode buffer containing 100 mm histidine, 0.002% Serva Blue G powder (SERVA electrophoresis), pH 8.0, and anode buffer containing 100 mm Tris, pH 8.8.
RESULTS
β-SH3 Dimerizes through a Single Disulfide Bond
Here, we studied the quaternary structure of β-SH3 by BN-PAGE that is particularly suited to analyze the oligomeric structure of proteins (31–34). The first hint that β-SH3 forms dimers came from size-exclusion chromatography of isolated β-SH3 indicating some degree of dimerization (35) and from non-reducing SDS-denaturing PAGE showing a small fraction resistant to denaturation (supplemental Fig. 1). In BN-PAGE, β-SH3 migrates in two bands, suggesting the co-existence of two oligomeric states (Fig. 1B). Incubation with SDS resulted in no significant changes in the mobility or relative intensity of both bands. In contrast, treatment with the reducing agent DTT causes the disappearance of the upper band, suggesting that this oligomer is generated by disulfide bonding. Because the mobility of the protein in non-denaturing electrophoresis depends on the shape, the numbers of monomers assembled per protein complex cannot be readily determined. To address this issue, we engineered a concatenated cDNA construct by linking two β-SH3 coding regions in a single open reading frame to yield a concatameric β-SH3 protein. This concatamer eluted from a size-exclusion column slightly earlier than its monomeric counterpart and was resolved at the expected molecular mass by reducing SDS-PAGE (Fig. 1C). In BN-PAGE, the upper band of the non-covalently linked β-SH3 migrated at the same position as the concatamer, demonstrating that it corresponds to a dimeric form and, accordingly, the lower molecular band to the monomeric form.
To further assess the contribution of disulfide bonding to dimer formation, we substituted the single cysteine residue in β-SH3, located at position 113, by alanine (β-SH3 C113A) and followed the same expression and purification methodology developed for wild-type β-SH3 (7). β-SH3 C113A elutes as a monodisperse peak from a size-exclusion column at the same position as wild-type β-SH3 (Fig. 1C), but in BN-PAGE, it migrates as a single band faster than the β-SH3 concatamer (Fig. 1D). This migration pattern was not altered by treatment with either SDS or DTT demonstrating that β-SH3 C113A does not form dimers. We conclude that wild-type β-SH3 forms homodimers bound covalently through a single disulfide bond involving cysteine residue 113.
β-SH3 C113A Dimerization-deficient Mutant Associates with Dynamin but Does Not Promote Endocytosis
We next examined whether the dimeric quaternary structure of β-SH3 plays a role in regulating endocytosis. In a standard pulldown assay, His-tagged wild-type and C113A β-SH3 used as bait brought down dynamin expressed in tsA201 cells (Fig. 2A). Thus, eliminating dimer-forming cysteine 113 did not prevent association with dynamin but, as revealed by charge-movement based internalization (CMBI) assay, it abolished the capability to promote endocytosis. The CMBI assay relies on the recording of the so-called gating currents from voltage-activated ion channels expressed in Xenopus oocytes (Fig. 2B). Gating currents arise from the displacement across the membrane of highly conserved basic residues within the voltage sensor of these channels at the onset of a voltage step (36). When recorded at the ionic current reversal potential, gating currents are void of contamination by ionic currents, and their integral equals the number of channels (N) times the number of charges displaced per channel (q) that is constant for each type of channel (37). Other methods to estimate the number of channels such as immunodetection of extracellularly epitope-tagged channels correlates well with CMBI measurements but do not allow simultaneous assessment of channel function (25). Fig. 2C shows the results of CMBI assay using the CaV1.2 isoform of CaVα1 before and after the injection of either wild-type β-SH3 or β-SH3 C113A. Although β-SH3 effectively reduces the number of channels in the plasma membrane, the C113A dimerization-deficient mutant does not, despite being capable of associating with dynamin. Thus, dimerization appears crucial to engage β-SH3 in the endocytic pathway.
Covalently Linking Two β-SH3 C113A Dimerization-deficient Mutant Molecules Restores Endocytosis
The observation that the β-SH3 C113A dimerization-deficient mutant binds dynamin but does not internalize channels predicts that bringing together two β-SH3 C113A molecules will rescue endocytosis. We engineered a concatamer β-SH3 C113A and compared it with the wild-type β-SH3 concatamer. Both concatamers eluted from a size-exclusion column at the same position (supplemental Fig. 2), and both retained the ability to associate with dynamin (Fig. 3A). The dimerization-competent molecules joined in a single polypeptide chain also retained the endocytic phenotype of the non-covalently linked β-SH3 (Fig. 3B), indicating that the molecular linkage did not introduce major structural rearrangements. More remarkably, linking two molecules of the dimerization-deficient mutant indeed restored β-SH3 ability to internalize CaV1.2 channels (Fig. 3C). This result highlights the functional relevance of β-SH3 dimerization for endocytosis.
Membrane-targeted CaVβ2a Isoform Forms Dimers
We have shown previously that when association with CaVα1 is prevented, CaVβ2a is as potent as the SH3 domain alone in downregulating HVA channels (7). CaVβ2a is a unique variant of CaVβ that undergoes dynamic palmitoylation (see Fig. 1A), and it is targeted to the plasma membrane even in the absence of the CaVα1 pore-forming subunit (38, 39). To investigate intermolecular interactions within CaVβ, we examined FRET occurrence between fluorophore-labeled CaVβ2a in living cells. Fluorophores CFP and YFP were fused to the C terminus to yield CaVβ2a-CFP and CaVβ2a-YFP, respectively. Fig. 4A shows the fluorescence emission spectra measured in a cuvette containing cells transfected with CaVβ2a-CFP and CaVβ2a-YFP encoding plasmid together or separately. Only cells coexpressing CaVβ2a-CFP and CaVβ2a-YFP demonstrated a larger emission peak at 525 nm concomitant with a smaller CFP emission that reflects the energy transferred from the donor CFP to the acceptor YFP. These results indicate that CaVβ2a oligomerizes within living cells. To calculate the apparent FRET efficiency (EfD) we applied the lux-FRET approach (28) and found that EfD was 10 ± 1% in co-transfected cells, whereas this value was 0 ± 1% in the mix of single transfected cells. Combination of FRET analysis with confocal microscopy revealed that CaVβ2a-CFP and CaVβ2a-YFP are localized almost entirely at the plasma membrane and that membrane-anchored CaVβ2a showed the highest EfD (10.8 ± 1.5%), whereas FRET value measured in minor cytosolic fraction of CaVβ2a (1.7 ± 0.4%) was close to that obtained for negative control (0 ± 0.4%) (Fig. 4B and supplemental Movie). Fusing the fluorescence proteins to the N-terminal end of CaVβ2a drastically change its intracellular localization from membrane-bound to homogenously distributed throughout the entire cell.
YFP and CFP proteins linked together in a single polypeptide chain (tandem construct) yields an EfD ∼35% when measured under the same experimental conditions. This value sets an upper limit of 17.5% to EfD in co-transfected cells as only 50% of the β-subunit dimers carry the YFP-CFP pair, the remaining fraction composed of YFP-YFP and CFP-CFP complexes are not detectable by FRET. Thus, the EfD of 10% obtained in the present study indicates that in intact cells an important fraction of CaVβ2a oligomerizes.
In BN-PAGE, CaVβ2a display a migration pattern consistent with dimer formation as it compares to the one obtained with a concatenated CaVβ protein construct (Fig. 4C). The CaVβ2a concatamer shows an additional band that corresponds to monomeric CaVβ likely produced by proteolysis (supplemental Fig. 3) (40). In contrast to β-SH3, CaVβ2a dimers were resistant to incubation with either SDS or DTT and could only be disrupted by treatment with both agents (Fig. 4C). Substitution of C113 by alanine (CaVβ2a C113A) did not prevent dimer formation (Fig. 4D), indicating that other regions of the full-length protein contribute to the dimerization interface. This idea is supported by our earlier experiments demonstrating that isolated GK domain forms dimers (18). In addition, a recent report showed higher-order oligomerization in cytoslic CaVβ variants coexpressed with the CaVα1 pore-forming subunit that depends on specific sites within the GK domain (41). From our experiments, the existence of less stable higher organized oligomeric forms of CaVβ2a cannot be excluded.
Preassociation of CaVβ2a with a Polypeptide Encoding Binding Motif of α1 Pore-forming AID Inhibits Endocytosis
We have shown previously that full-length CaVβ2a is as efficient as the SH3 domain to promote endocytosis of CaVα1 when association to it is prevented and that it also induces internalization of the distantly related Shaker potassium channel (7). Deletion of the highly conserved AID sequence located in the intracellular loop joining the first and second domain of CaV1.2 (CaV1.2 ΔAID) effectively disrupts any CaVβ-CaVα1 association. Here, we used the same strategy to follow endocytosis mediated by CaVβ2a. CaV1.2 ΔAID channels were internalized by CaVβ2a wild-type as well as by the C113A mutant. This result emphasizes that dimer formation rather than the chemical nature of the residue at this position is critical for endocytosis (Fig. 5A). The fact that CaVβ2a efficiently internalizes channels lacking the AID site suggests that its association with the pore-forming subunit hinders channel internalization. To test this idea, we preincubated CaVβ2a with GST-AID, a GST-fusion protein that included the AID sequence, and performed CMBI assay. Association of CaVβ2a with the AID site inhibited endocytosis (Fig. 5B). These findings are consistent with a model whereby channel activation and internalization are mutually exclusive functions of CaVβ.
α1 Pore-forming Subunit Impairs Dimer Formation of CaVβ2a
Because it is well established that only one β-subunit is required to recapitulate channel function, it is likely that association with CaVα1 disrupts dimerization. The latter would explain why co-incubation with the AID channel peptide inhibits endocytosis (Fig. 5B) and also why we did not observe β-mediated endocytosis in the wild-type channel but did observe it in channels lacking the AID site (7). We performed the same FRET analysis shown in Fig. 4A but this time in the presence of CaV1.2. We observed a decrease in EfD of almost 50% when fluorescently labeled CaVβ2a proteins are coexpressed together with the α1 pore-forming subunit (Fig. 5C).
DISCUSSION
It is increasingly evident that SH3-containing proteins expand their functional diversity by dimerization. For example, in islet brain 1 protein, mutations that destabilize dimer formation do not affect binding with the proline-rich region containing partner c-Jun N-terminal kinase but impairs its ability to regulate insulin secretion (23). In the case of CT10 regulator of kinase-like adaptor protein, a functionally relevant nuclear export signal becomes available only after a conformational change induced by homodimerization (24). Dimerization of β-SH3 could position two dynamin molecules together promoting its oligomerization and GTPase activity (42) or could bring dynamin close to other proteins of the endocytic machinery, serving as a local adaptor that recruits an active endocytic complex. This idea is supported by the observation that two β-SH3 modules brought together by either a disulfide bond or by a covalently attached peptide linker are equally competent for activation of endocytosis. Thus, closeness of the two SH3 domains appears sufficient for function as opposed to the requirement of a precise geometry of the two dynamin binding sites within the quaternary structure of the dimer. Possible candidates to be recruited are members of the Ras superfamily of monomeric small GTPases known to inhibit CaV1.2-mediated currents by interacting with CaVβ subunits (43). Furthermore, the effect of the Ras protein REM involves dynamin-dependent endocytosis (44), suggesting that REM and dynamin may simultaneously interact with the CaVβ dimer to inhibit calcium currents. The repertoire of regulatory inputs to the endocytic machinery may be augmented even further in full-length CaVβ by the GK domain, which also appears as a protein-protein interaction domain (45–47). Interaction of kinesin-like proteins with GK domains (48) suggests that CaVβ may be engaged in the sorting of the endocytic vesicle by motor proteins. We have already proposed that the functional duality of CaVβ constitutes an efficient quality control mechanism in which the same protein ensures functional fitness and survival of the channel in the plasma membrane (7). In this context, it appears natural to think that channels internalized by CaVβ are directed to early endosomes for recycling rather than to lysosomes for degradation.
Our results hint to a mutual exclusion between channel activation and internalization by CaVβ. Whether this functional divergence correlates with CaVβ ability to form dimers when associated to CaVα1 remains controversial. Although it is well established that a single CaVβ molecule or β-GK alone fully reconstitutes modulation of HVA channels (18, 49), a recent report suggests that CaVβ oligomers can also bind to the channel and augment current density (41). The authors attributed this current increase to changes in the functional properties of the channels that they correlate to CaVβ3 oligomerization induced by a β-GK fragment. Alternative scenarios are that additional monomeric CaVβ3 increases the fraction of the CaV1.2 subunit complexed with β-subunit or recruits CaVα1-CaVβ channel complexes to the plasma membrane, both augmenting current density (49). Unfortunately, the lack of quantification of the number of channels in the plasma membrane does not allow unambiguous distinction between alterations in channel function or expression.
The number of binding partners and functions of CaVβ is rapidly increasing (4, 50). Very distantly related proteins have been shown to associate with CaVβ, including Rem, Rad, kir/Gem (RGK) GTPases, Ahnak, RIM1, bestrophin, heterochromatin protein 1, a yet to be identified member of intracellular calcium stores, and dynamin. Although the exact sequence of events for the switch between CaVα1-CaVβ channel to the (CaVβ)2-dynamin complex and the physiological signal that triggers dissociation of the β-subunit from its traditional CaVα1 partner have yet to be established, we do know that α1-β interaction is indeed reversible (25). This fact by itself predicts the presence of free β-subunit that can then interact with other ligands besides CaVα1.
In promiscuous proteins, specific associations are often regulated by their structural flexibility. This type of regulation is well documented for the classical members of the membrane-associated guanylate kinase family in which association of ligands with other regions of the molecule regulates GK binding (51–55). The proposed mechanism is that ligands influence SH3-GK intramolecular interactions producing a conformational change within the GK domain that changes the affinity for its partners. For example, upon binding to calmodulin, the synapse-associated protein SAP97 weakens the SH3-GK interaction allowing the accessibility of GK by other proteins (56). Similarly, the SH3-GK interaction that also exists in the β-protein (57–59) may be favored by binding with high affinity to the α1-subunit. Thus, when complexed with the channel, CaVβ intramolecular interactions dominate over intermolecular associations. This is consistent with the FRET analysis showing that dimer formation of CaVβ is reduced in the presence of the α1-subunit. On the contrary, by binding to the SH3 domain, dynamin could weaken intramolecular interactions and favors dimer formation and dissociation from the channel. Our study suggests that dimerization contributes to the functional versatility of CaVβ and represents the switch from channel activator to channel internalizer (Fig. 6). Dimerization would endow CaVβ with an additional handle to expand the dynamic range over which this protein controls the spatio-temporal profile of calcium signals. After all, the modular architecture of CaVβ appears very well suited to orchestrate calcium signaling.
One point that needs to be addressed directly is whether dynamin bind to CaVβ when it is complexed to the α1-subunit. It would be also interesting to know whether post-translational modifications regulate SH3/GK interactions (60).
The existence of multiple pathways in the regulation of calcium currents by CaVβ imposes new theoretical considerations for therapy design. Several evidences suggest that alterations in CaVβ2 underlie some forms of myocardial dysfunction (61–64), and so far, gene therapy to inhibit CaVβ2 has been considered only in correlation to an electrophysiological phenotype (65).
Supplementary Material
Acknowledgments
We thank Dr. Christoph Fahlke for insightful discussion and Rodrigo Neely for reading the manuscript.
This work was supported by grants from the Deutsche Forschungsgemeinschaft Grants DFG Hi 800/3-1 and 4-1 (to P. H.), Red de Anillo de Ciencia y Tecnologia Grant RED-24 (to A. N.), and the German-Chilean Scientific Cooperation Program Deutsche Forschungsgemeinschaft-Comisión Nacional de Investigación Científica y Tecnológica 2010 (to P. H. and A. N.).
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3, a movie, and additional references.
- HVA
- high voltage-activated channel(s)
- CaVα1
- α1 pore-forming subunit of HVA channel(s)
- CaVβ
- accessory β-subunit of HVA channel(s)
- SH3
- Src homology 3
- GK
- guanylate kinase
- AID
- α1-interaction domain
- BN-PAGE
- blue native PAGE
- CMBI
- charge-movement based internalization
- EfD
- apparent FRET efficiency
- CFP
- Cyan Fluorescent Protein
- pC
- pico Coulomb.
REFERENCES
- 1. Catterall W. A. (2000) Annu. Rev. Cell Dev. Biol. 16, 521–555 [DOI] [PubMed] [Google Scholar]
- 2. Arikkath J., Campbell K. P. (2003) Curr. Opin. Neurobiol. 13, 298–307 [DOI] [PubMed] [Google Scholar]
- 3. Dolphin A. C. (2003) J. Bioenerg. Biomembr. 35, 599–620 [DOI] [PubMed] [Google Scholar]
- 4. Hidalgo P., Neely A. (2007) Cell Calcium 42, 389–396 [DOI] [PubMed] [Google Scholar]
- 5. Berggren P. O., Yang S. N., Murakami M., Efanov A. M., Uhles S., Köhler M., Moede T., Fernström A., Appelskog I. B., Aspinwall C. A., Zaitsev S. V., Larsson O., de Vargas L. M., Fecher-Trost C., Weissgerber P., Ludwig A., Leibiger B., Juntti-Berggren L., Barker C. J., Gromada J., Freichel M., Leibiger I. B., Flockerzi V. (2004) Cell 119, 273–284 [DOI] [PubMed] [Google Scholar]
- 6. Hibino H., Pironkova R., Onwumere O., Rousset M., Charnet P., Hudspeth A. J., Lesage F. (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 307–312 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Gonzalez-Gutierrez G., Miranda-Laferte E., Neely A., Hidalgo P. (2007) J. Biol. Chem. 282, 2156–2162 [DOI] [PubMed] [Google Scholar]
- 8. Chen Y. H., Li M. H., Zhang Y., He L. L., Yamada Y., Fitzmaurice A., Shen Y., Zhang H., Tong L., Yang J. (2004) Nature 429, 675–680 [DOI] [PubMed] [Google Scholar]
- 9. Opatowsky Y., Chen C. C., Campbell K. P., Hirsch J. A. (2004) Neuron 42, 387–399 [DOI] [PubMed] [Google Scholar]
- 10. Van Petegem F., Clark K. A., Chatelain F. C., Minor D. L., Jr. (2004) Nature 429, 671–675 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Hinshaw J. E. (2000) Annu. Rev. Cell Dev. Biol. 16, 483–519 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Praefcke G. J., McMahon H. T. (2004) Nat. Rev. Mol. Cell Biol. 5, 133–147 [DOI] [PubMed] [Google Scholar]
- 13. Gout I., Dhand R., Hiles I. D., Fry M. J., Panayotou G., Das P., Truong O., Totty N. F., Hsuan J., Booker G. W. (1993) Cell 75, 25–36 [PubMed] [Google Scholar]
- 14. David C., McPherson P. S., Mundigl O., de Camilli P. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 331–335 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Shupliakov O., Löw P., Grabs D., Gad H., Chen H., David C., Takei K., De Camilli P., Brodin L. (1997) Science 276, 259–263 [DOI] [PubMed] [Google Scholar]
- 16. Mayer B. J. (2001) J. Cell Sci. 114, 1253–1263 [DOI] [PubMed] [Google Scholar]
- 17. Pragnell M., De Waard M., Mori Y., Tanabe T., Snutch T. P., Campbell K. P. (1994) Nature 368, 67–70 [DOI] [PubMed] [Google Scholar]
- 18. Gonzalez-Gutierrez G., Miranda-Laferte E., Nothmann D., Schmidt S., Neely A., Hidalgo P. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 14198–14203 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Dzhura I., Neely A. (2003) Biophys. J. 85, 274–289 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Kanevsky N., Dascal N. (2006) J. Gen. Physiol. 128, 15–36 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Herzig S., Khan I. F., Gründemann D., Matthes J., Ludwig A., Michels G., Hoppe U. C., Chaudhuri D., Schwartz A., Yue D. T., Hullin R. (2007) FASEB J. 21, 1527–1538 [DOI] [PubMed] [Google Scholar]
- 22. Wigge P., Köhler K., Vallis Y., Doyle C. A., Owen D., Hunt S. P., McMahon H. T. (1997) Mol. Biol. Cell 8, 2003–2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Kristensen O., Guenat S., Dar I., Allaman-Pillet N., Abderrahmani A., Ferdaoussi M., Roduit R., Maurer F., Beckmann J. S., Kastrup J. S., Gajhede M., Bonny C. (2006) EMBO J. 25, 785–797 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Harkiolaki M., Gilbert R. J., Jones E. Y., Feller S. M. (2006) Structure 14, 1741–1753 [DOI] [PubMed] [Google Scholar]
- 25. Hidalgo P., Gonzalez-Gutierrez G., Garcia-Olivares J., Neely A. (2006) J. Biol. Chem. 281, 24104–24110 [DOI] [PubMed] [Google Scholar]
- 26. Neely A., Garcia-Olivares J., Voswinkel S., Horstkott H., Hidalgo P. (2004) J. Biol. Chem. 279, 21689–21694 [DOI] [PubMed] [Google Scholar]
- 27. Kobe F., Renner U., Woehler A., Wlodarczyk J., Papusheva E., Bao G., Zeug A., Richter D. W., Neher E., Ponimaskin E. (2008) Biochim. Biophys. Acta 1783, 1503–1516 [DOI] [PubMed] [Google Scholar]
- 28. Wlodarczyk J., Woehler A., Kobe F., Ponimaskin E., Zeug A., Neher E. (2008) Biophys. J. 94, 986–1000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Woehler A., Wlodarczyk J., Ponimaskin E. G. (2009) Glycoconj. J. 26, 749–756 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Niepmann M., Zheng J. (2006) Electrophoresis 27, 3949–3951 [DOI] [PubMed] [Google Scholar]
- 31. Schägger H., Cramer W. A., von Jagow G. (1994) Anal. Biochem. 217, 220–230 [DOI] [PubMed] [Google Scholar]
- 32. Horiuchi M., Nicke A., Gomeza J., Aschrafi A., Schmalzing G., Betz H. (2001) Proc. Natl. Acad. Sci. U.S.A. 98, 1448–1453 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Gendreau S., Voswinkel S., Torres-Salazar D., Lang N., Heidtmann H., Detro-Dassen S., Schmalzing G., Hidalgo P., Fahlke C. (2004) J. Biol. Chem. 279, 39505–39512 [DOI] [PubMed] [Google Scholar]
- 34. Detro-Dassen S., Schänzler M., Lauks H., Martin I., zu Berstenhorst S. M., Nothmann D., Torres-Salazar D., Hidalgo P., Schmalzing G., Fahlke C. (2008) J. Biol. Chem. 283, 4177–4188 [DOI] [PubMed] [Google Scholar]
- 35. McGee A. W., Nunziato D. A., Maltez J. M., Prehoda K. E., Pitt G. S., Bredt D. S. (2004) Neuron 42, 89–99 [DOI] [PubMed] [Google Scholar]
- 36. Bezanilla F., Stefani E. (1998) Methods Enzymol. 293, 331–352 [DOI] [PubMed] [Google Scholar]
- 37. Noceti F., Baldelli P., Wei X., Qin N., Toro L., Birnbaumer L., Stefani E. (1996) J. Gen. Physiol. 108, 143–155 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Chien A. J., Carr K. M., Shirokov R. E., Rios E., Hosey M. M. (1996) J. Biol. Chem. 271, 26465–26468 [DOI] [PubMed] [Google Scholar]
- 39. Chien A. J., Gao T., Perez-Reyes E., Hosey M. M. (1998) J. Biol. Chem. 273, 23590–23597 [DOI] [PubMed] [Google Scholar]
- 40. Nicke A., Rettinger J., Schmalzing G. (2003) Mol. Pharmacol. 63, 243–252 [DOI] [PubMed] [Google Scholar]
- 41. Lao Q. Z., Kobrinsky E., Liu Z., Soldatov N. M. (2010) FASEB J. 24, 5013–5023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Warnock D. E., Hinshaw J. E., Schmid S. L. (1996) J. Biol. Chem. 271, 22310–22314 [DOI] [PubMed] [Google Scholar]
- 43. Béguin P., Nagashima K., Gonoi T., Shibasaki T., Takahashi K., Kashima Y., Ozaki N., Geering K., Iwanaga T., Seino S. (2001) Nature 411, 701–706 [DOI] [PubMed] [Google Scholar]
- 44. Yang T., Xu X., Kernan T., Wu V., Colecraft H. M. (2010) J. Physiol. 588, 1665–1681 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Kim E., Naisbitt S., Hsueh Y. P., Rao A., Rothschild A., Craig A. M., Sheng M. (1997) J. Cell Biol. 136, 669–678 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Takeuchi M., Hata Y., Hirao K., Toyoda A., Irie M., Takai Y. (1997) J. Biol. Chem. 272, 11943–11951 [DOI] [PubMed] [Google Scholar]
- 47. Mathew D., Gramates L. S., Packard M., Thomas U., Bilder D., Perrimon N., Gorczyca M., Budnik V. (2002) Curr. Biol. 12, 531–539 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Hanada T., Lin L., Tibaldi E. V., Reinherz E. L., Chishti A. H. (2000) J. Biol. Chem. 275, 28774–28784 [DOI] [PubMed] [Google Scholar]
- 49. Dalton S., Takahashi S. X., Miriyala J., Colecraft H. M. (2005) J. Physiol. 567, 757–769 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Buraei Z., Yang J. (2010) Physiol. Rev. 90, 1461–1506 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Brenman J. E., Topinka J. R., Cooper E. C., McGee A. W., Rosen J., Milroy T., Ralston H. J., Bredt D. S. (1998) J. Neurosci. 18, 8805–8813 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Tavares G. A., Panepucci E. H., Brunger A. T. (2001) Mol. Cell 8, 1313–1325 [DOI] [PubMed] [Google Scholar]
- 53. Qian Y., Prehoda K. E. (2006) J. Biol. Chem. 281, 35757–35763 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Reese M. L., Dakoji S., Bredt D. S., Dötsch V. (2007) Nat. Struct. Mol. Biol. 14, 155–163 [DOI] [PubMed] [Google Scholar]
- 55. Newman R. A., Prehoda K. E. (2009) J. Biol. Chem. 284, 12924–12932 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Paarmann I., Spangenberg O., Lavie A., Konrad M. (2002) J. Biol. Chem. 277, 40832–40838 [DOI] [PubMed] [Google Scholar]
- 57. Opatowsky Y., Chomsky-Hecht O., Kang M. G., Campbell K. P., Hirsch J. A. (2003) J. Biol. Chem. 278, 52323–52332 [DOI] [PubMed] [Google Scholar]
- 58. Takahashi S. X., Miriyala J., Colecraft H. M. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 7193–7198 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Takahashi S. X., Miriyala J., Tay L. H., Yue D. T., Colecraft H. M. (2005) J. Gen. Physiol. 126, 365–377 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Sabio G., Arthur J. S., Kuma Y., Peggie M., Carr J., Murray-Tait V., Centeno F., Goedert M., Morrice N. A., Cuenda A. (2005) EMBO. J. 24, 1134–1145 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Weissgerber P., Held B., Bloch W., Kaestner L., Chien K. R., Fleischmann B. K., Lipp P., Flockerzi V., Freichel M. (2006) Circ. Res. 99, 749–757 [DOI] [PubMed] [Google Scholar]
- 62. Hullin R., Matthes J., von Vietinghoff S., Bodi I., Rubio M., D'Souza K., Friedrich Khan I., Rottländer D., Hoppe U. C., Mohacsi P., Schmitteckert E., Gilsbach R., Bünemann M., Hein L., Schwartz A., Herzig S. (2007) PLoS One 2, e292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Link S., Meissner M., Held B., Beck A., Weissgerber P., Freichel M., Flockerzi V. (2009) J. Biol. Chem. 284, 30129–30137 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Koval O. M., Guan X., Wu Y., Joiner M. L., Gao Z., Chen B., Grumbach I. M., Luczak E. D., Colbran R. J., Song L. S., Hund T. J., Mohler P. J., Anderson M. E. (2010) Proc. Natl. Acad. Sci. U.S.A. 107, 4996–5000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Cingolani E., Ramirez Correa G. A., Kizana E., Murata M., Cho H. C., Marbán E. (2007) Circ. Res. 101, 166–175 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.